Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 783. The contact email is not on this page.
- KEYBIOME INC
NIH R42: Aim protein-based anti-inflammatory therapeutic for the treatment of IBD
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NCAP MEDICAL, LLC
NIH R41: Enhancing pain management for knee replacement patients through an innovative non-invasive and opioid-sparing device
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CIRCUMVENT PHARMACEUTICALS, INC.
NIH R44: Development of N-tert-(butyl)hydroxylamine (NtBuHA) as a Therapeutic Agent for Treating CLN1 Batten Disease
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PERFUSIO CORP.
NIH R43: Project MATCH: Multi-spectral AI/ML powered Burn and Wound Evaluation Technology using a Cost-Effective Handheld Device.
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENDOMIMETICS, LLC
NIH R43: Atherosclerosis assay development for drug efficacy and cytotoxicity screening
startup · AL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BioSymetrics
BioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicines.
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SENEX BIOTECHNOLOGY, INC.
NIH R41: Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- WNT SCIENTIFIC, LLC
NIH R43: Intraarticular injection of Wnt inhibitor for osteoarthritis therapy
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- APT THERAPEUTICS, INC.
NIH R44: Multi-functional anti-thrombotic therapy for coronary microvascular obstruction
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AAIIT LLC
NIH R43: Protein display drug ANDI reduces asthmatic airway hyperreactivity
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TRANSCHROMIX, LLC.
NIH R41: Targeting novel translation mechanism to treat NFOO-induced hypoxia-related brain injuries
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- D4Z4 MEDICINE, INC.
NIH R41: Long-read sequencing-based diagnosis for complex genomic and DNA methylation changes
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- WELLSIM BIOMEDICAL TECHNOLOGIES, INC.
NIH R44: Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KOLI, INC.
NIH R44: Koli: A non-surgical solution for gallstone disease
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DABBLE HEALTH, INC.
NIH R43: Ecological Cognitive Monitoring through AI-Enhanced Personal Photo Activities
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KINEA BIO, INC.
NIH R44: Development of novel genetic medicine approaches to treat orphan diseases
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INTERO BIOSYSTEMS INC.
NIH R44: A Novel Multi-Lineage Human Intestinal Organoid Screening Platform for Drug Discovery and Preclinical Testing
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Kytopen
Kytopen seeks to expand patient access to the next generation of living medicines through scalable genome engineering platforms by solving cell therapy manufacturing problems at the discovery stage. Their non-viral gene delivery platform empowers researchers and developers to acc
startup · MA · amount not stated · 2025-02-20
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-02-20.
- VESTO THERAPEUTICS, INC
NIH R43: De Novo Minibinder Radiotheranostics for Targeted Treatment of Prostate Cancer
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CRANIOSURE LLC
NIH R41: Development and Validation of a Novel AI-Augmented Mobile Platform for Early Head Shape Screening in Infants.
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CROSSLIFE TECHNOLOGIES, INC.
NIH R44: Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Trevarx Biomedical, Inc.
Form D history: Biotechnology
startup · PA · amount not stated · 2025-08-04
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-08-04.
- MOLECULAR INSTRUMENTS, INC.
NIH R44: Hybridization Chain Reaction: Automated Ultrasensitive Multiplex RNA and Protein Imaging
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CURATIX, LLC
NIH R43: Antifungals targeting pantothenate phosphorylation
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Bloomer Health Tech, Inc.
Form D history: Biotechnology
startup · MA · amount not stated · 2020-03-12
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2020-03-12.
- JACARANDA BIOSCIENCES, INC.
NIH R43: Development of UPR-Targeted Treatment for Cisplatin-Induced Ototoxicity.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IMMUTO SCIENTIFIC, INC.
NIH R44: Plasma-Generated Hydroxyl Radicals for Analysis of Three-Dimensional Structures in Protein Therapeutics
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEUROSCOPE INC.
NIH R44: Development of perivascular space mapping toolset as a diagnostic aid for Alzheimer's disease
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VEST INC.
NIH R44: Mobius Accessibility Mounting System and Assistive Technology Product Line to Support Independence and Safety for Older Adults and Persons with Disabilities
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MOUNTAIN BIOMETRICS, INC
NIH R44: Unlocking Medical AI: A Scalable, Privacy-Preserving Annotation Platform for Clinical and Physiological Data
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RADIATION MONITORING DEVICES, INC.
NIH R44: Semiconductor detector for low-dose, high-resolution dental DR imaging
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OraLiva, Inc.
Form D history: Biotechnology
startup · NC · amount not stated · 2025-03-21
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-03-21.
- TAESUN, LLC
NIH R43: A comprehensive device integrating fentanyl test strips with sample preparation features for convenient and discreet fentanyl testing in high-risk environments
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CAREVIRTUE TECHNOLOGIES, INC.
NIH R44: Reducing ADRD Caregiver Burden With a Novel AI Voice Agent and Automated Workflow Solution for Adult Day Service (ADS) Providers.
startup · DE · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- POP BIOTECHNOLOGIES, INC
NIH R41: Liposome-displayed ApoB fragment for active immunotherapy against atherosclerosis
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HAVA, INC.
NIH R44: Rapid Production of Metal Organic Framework - Fabrics for Air Filtration
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SPIRIT FIT & HEALTH INC
NIH R44: SPIRIT Club CBI Pathway: A novel streaming platform for physical activity and wellness promotion for chronic brain injury survivors
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PULMONESCENCE DIAGNOSTICS, INC.
NIH R41: Non-Invasive Rapid Test for Pediatric Tuberculosis
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- JAVELIN BIOTECH
NIH R44: Hepatic Clearance Chip for Pharmacokinetics
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CARDIAC RSK3 INHIBITORS, LLC
NIH R44: RSK3 Anchoring Disruptor Therapy for Heart Failure
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.